Page last updated: 2024-10-15

3-hydroxykynurenine and Pancreatic Neoplasms

3-hydroxykynurenine has been researched along with Pancreatic Neoplasms in 1 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, JY1
Butler, LM1
Midttun, Ø1
Ulvik, A1
Wang, R1
Jin, A1
Gao, YT1
Ueland, PM1
Koh, WP1
Yuan, JM1

Other Studies

1 other study available for 3-hydroxykynurenine and Pancreatic Neoplasms

ArticleYear
A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer.
    PloS one, 2018, Volume: 13, Issue:5

    Topics: 3-Hydroxyanthranilic Acid; Biomarkers; Case-Control Studies; China; Female; Humans; Kynurenine; Male

2018